Cite
Universidad Autonoma de Guadalajara Researchers Yield New Data on Adenocarcinoma [Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility]
MLA
“Universidad Autonoma de Guadalajara Researchers Yield New Data on Adenocarcinoma [Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility].” Health & Medicine Week, 12 Apr. 2024, p. 7824. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.789229547&authtype=sso&custid=ns315887.
APA
Universidad Autonoma de Guadalajara Researchers Yield New Data on Adenocarcinoma [Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility]. (2024, April 12). Health & Medicine Week, 7824.
Chicago
Health & Medicine Week. 2024. “Universidad Autonoma de Guadalajara Researchers Yield New Data on Adenocarcinoma [Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility],” April 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.789229547&authtype=sso&custid=ns315887.